UNH vs MRNA
By Alex · Tickerpine
UnitedHealth Group Incorporated vs Moderna, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | UNH | MRNA |
|---|---|---|
| Price | $407.46 | $223.37 |
| Market cap | $365.09B | $90.38B |
| P/E ratio | 23.3 | — |
| ROE | 15.77% | -34.50% |
| Profit margin | 3.53% | -110.45% |
| Revenue growth | -0.40% | 29.20% |
| Dividend yield | 2.28% | 0.00% |
| Beta | 0.52 | 1.17 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
UNH vs MRNA in plain English
- UNH is the bigger company — about 4.0× the market cap of MRNA.
- UNH earns a higher return on equity (16% vs -35%).
- MRNA is growing revenue faster (29% vs -0%).
- UNH pays a dividend (2.28%) while the other effectively doesn't.
How would $1,000 have done in each?
UNH return calculator
See what $1,000 in UnitedHealth Group Incorporated would be worth today.
MRNA return calculator
See what $1,000 in Moderna, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.